The Poland infection control market is evaluated at US$121.656 million for the year 2020 and is projected to grow at a CAGR of 4.85% to reach a market size of US$169.506 million by the year 2027.
Owing to the great scope of improvement in the polish healthcare sector, the Polish population has one of the lowest life expectancies in Europe. The Social Health Insurance system offers a wide range of benefits, but there are significant coverage gaps, most notably for outpatient medications. The health system overly relies on hospital care and is short on health workers, particularly primary care doctors. The main causes of death are heart disease, followed by stroke, and lung cancer. Moreover, more than half the population has reported depression, compared to a fifth in the European Union (EU). Tobacco and alcohol consumption are more prevalent in Poland than in Western Europe, and cirrhosis-related deaths among young and middle-aged adults have not decreased. Overweight and obesity rates in adults and children have increased significantly.
Infection control teams and ward staff should consider the practical implications when developing procedures and management, especially given the difficulties in implementing effective teamwork in interdisciplinary teams, which is a major challenge for health professionals working in acute hospitals. Although there is no large network/surveillance programme in Poland that is based on active, continuous monitoring and registration.
Public spending on health care is expected to rise by 0.8 purchasing power standards (PPS) of GDP, less than the EU average of 0.9 (PPS). When the impact of non-demographic drivers on future spending growth is considered ("AWG risk scenario"), healthcare expenditure is expected to rise by 1.7 percentage points of GDP from now until 2070, compared to the EU average of 1.6 (PPS).
91.6 percent of the population is covered by public health insurance. Almost all social groups are required to have health insurance. Contracts between individual entities and the National Health Fund are used to fund hospitals. The contracts are based on a uniform classification of hospital services, which is primarily based on defining individual groups of procedures and prices for basic units.
Furthermore, over the last decade, the number of hospital beds per citizen has remained stable. However, a new regulation implemented in 2019 that ties hospital nurse employment quotas to the number of hospital beds is causing hospital management to reduce the number of beds in response to recent increases in nurses' salaries. Despite the latter, which can retard the progress of healthcare expenditure marginally, the need for healthcare services to be provided is great, especially on account of chronic diseases repaired by the adult population aged 65 or over. Along with the aforementioned, the treatment of chronic diseases needs longer inpatient care, among others. As a result, in order to avoid healthcare-associated illness, the administration of various healthcare points must invest in a variety of infection control products, which is expected to drive the growth of the Infection Control Market in Poland during the forecast period.
Recent development and expansions
Medicover has completed its acquisition of CDT Medicus Group (CDT), a leading regional provider of medical services in the Legnicko-Glogowski Okreg Miedziowy (LGOM) region of Southwestern Poland. As of January 28, 2022, the acquisition will be consolidated.
COVID-19 impact on Poland Infection Control Market
In Poland, passage across the state border was restricted in some ways, including by air and rail. Citizens were advised not to leave their homes unless absolutely necessary. The government closed all educational facilities, including childcare centers. Passport control was implemented at all of the country's land borders, and only Poles were permitted to enter. All citizens were required to quarantine for 14 days upon their arrival. All public events are now prohibited. Entertainment and food service outlets were closed. During the first and second waves of COVID, Poland took a different path, providing a natural experiment on how the form and timing of lockdown policies can affect economic slowdown and virus containment. During the first and second waves of COVID, Poland took different paths providing a natural experiment on how the form and timing of lockdown policies can affect economic slowdown and virus containment. Despite the fact that the Polish economy appears to have performed admirably during the pandemic.
Poland Infection Control Market Scope:
| Report Metric |
Details |
| Study Period |
2021 to 2031 |
| Historical Data |
2021 to 2024 |
| Base Year |
2025 |
| Forecast Period |
2026 – 2031 |
| Report Metric |
Details |
| Market Size Value in 2020 |
US$121.656 million |
| Market Size Value in 2027 |
US$169.506 million |
| Growth Rate |
CAGR of 4.85% from 2020 to 2027 |
| Base Year |
2020 |
| Forecast Period |
2022–2027 |
| Forecast Unit (Value) |
USD Million |
| Segments Covered |
Product, And End-User Industry |
| Companies Covered |
DE LAMA S.P.A.[1], H.W. Andersen Products Ltd., Sartorius AG, SMS sp. z o.o., Steriflow |
| Customization Scope |
Free report customization with purchase |
Market Segmentation:
- By Product
- Disinfectant
- Sterilization
- Low temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
